Companies /Basic Materials
Linde Plc.
NASDAQ: LIN Specialty Chemicals
$523.92
▼ $2.15 (−0.41%) today
Markets open · 3:18pm ET

Linde (LIN) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
LIN vs Market · 30-day return after each reportLINS&P 500
0%+3%+6%+5.3%+6.7%Q1 25+2.7%+3.5%Q2 25−2.2%+0.3%Q3 25+4.0%−0.1%Q4 25−0.1%+4.7%Q1 26+1.8%+2.0%Q2 26
0%+3%+6%Q1 25Q3 25Q1 26
LIN EPS Trend · estimate vs actualEstimateActual
$0$2$4$3.92$3.95Q1 25$4.04$4.09Q2 25$4.18$4.21Q3 25$4.18$4.20Q4 25$4.27$4.33Q1 26$4.49$4.50Q2 26$4.52$4.59Q3 26
$0$2$4Q1 25Q3 25Q1 26Q3 26
LIN Revenue Trend · estimate vs actualEstimateActual
$0$3.0B$6.0B$9.0B$8.3B$8.1BQ1 25$8.4B$8.5BQ2 25$8.6B$8.6BQ3 25$8.6B$8.8BQ4 25$8.6B$8.8BQ1 26$9.2B$9.4BQ3 26
$0$3.0B$6.0B$9.0BQ1 25Q3 25Q1 26

How Often Does Linde Beat Earnings Estimates?

Linde beat EPS estimates in 7 of its last 7 reported quarters, and has beaten 7 quarters in a row.

LIN quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 Adjusted EPS excludes Linde AG purchase accounting impacts and cost reduction program and other charges; GAAP diluted EPS was $3.66 (down 11%) and GAAP net income was $1,692 million versus adjusted net income of $2,122 million. $4.59 est. $4.52 +1.60% $9.4B est. $9.2B +2.64%
Q2 2026 $4.50 est. $4.49 +0.22% $9.3B —
Q1 2026 $4.33 est. $4.27 +1.40% $8.8B est. $8.6B +2.09%
Q4 2025 $4.20 est. $4.18 +0.55% $8.8B est. $8.6B +1.35%
Q3 2025 $4.21 est. $4.18 +0.75% $8.6B est. $8.6B −0.01%
Q2 2025 $4.09 est. $4.04 +1.36% $8.5B est. $8.4B +1.40%
Q1 2025 $3.95 est. $3.92 +0.68% $8.1B est. $8.3B −1.69%

Figures from SEC filings and company reports. Not investment advice.